PubMed (RefSeq) for id: 1653961925

Year	Number of Results
1969	1
1975	1
1977	3
1980	1
1981	1
1983	1
1987	2
1988	1
1990	3
1992	1
1993	1
1994	2
1995	2
1996	1
1997	2
1998	2
1999	2
2000	2
2001	3
2002	9
2003	9
2004	11
2005	11
2006	8
2007	16
2008	9
2009	13
2010	16
2011	9
2012	15
2013	13
2014	8
2015	10
2016	12
2017	10
2018	10
2019	8
2020	12
2021	9
2022	9
2023	8
2024	4

1

The Binding of the SARS-CoV-2 Spike Protein to Platelet Factor 4: A Proposed Mechanism for the Generation of Pathogenic Antibodies.

Nguyen TH, Chen LY, Khan NZ, Lindenbauer A, Bui VC, Zipfel PF, Heinrich D. Nguyen TH, et al. Biomolecules. 2024 Feb 20;14(3):245. doi: 10.3390/biom14030245. Biomolecules. 2024. PMID: 38540666 Free PMC article.

2

Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.

Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, Zhang Y, Wang HY, Chen L, Qiu X. Wang K, et al. Cancer Lett. 2024 Apr 1;586:216690. doi: 10.1016/j.canlet.2024.216690. Epub 2024 Feb 1. Cancer Lett. 2024. PMID: 38307410 Free article.

3

Platelet factor 4(PF4) and its multiple roles in diseases.

Liu Z, Li L, Zhang H, Pang X, Qiu Z, Xiang Q, Cui Y. Liu Z, et al. Blood Rev. 2024 Mar;64:101155. doi: 10.1016/j.blre.2023.101155. Epub 2023 Nov 23. Blood Rev. 2024. PMID: 38008700 Review.

4

Platelet factor 4 limits neutrophil extracellular trap- and cell-free DNA-induced thrombogenicity and endothelial injury.

Ngo AT, Skidmore A, Oberg J, Yarovoi I, Sarkar A, Levine N, Bochenek V, Zhao G, Rauova L, Kowalska MA, Eckart K, Mangalmurti NS, Rux A, Cines DB, Poncz M, Gollomp K. Ngo AT, et al. JCI Insight. 2023 Nov 22;8(22):e171054. doi: 10.1172/jci.insight.171054. JCI Insight. 2023. PMID: 37991024 Free PMC article.

5

PF4 activates the c-Mpl-Jak2 pathway in platelets.

Buka RJ, Montague SJ, Moran LA, Martin EM, Slater A, Watson SP, Nicolson PLR. Buka RJ, et al. Blood. 2024 Jan 4;143(1):64-69. doi: 10.1182/blood.2023020872. Blood. 2024. PMID: 37883794 Free PMC article.

6

Platelet factor 4 (PF4) induces cluster of differentiation 40 (CD40) expression in human aortic endothelial cells (HAECs) through the SIRT1/NF-κB/p65 signaling pathway.

Zhong M, Wang XH, Zhao Y. Zhong M, et al. In Vitro Cell Dev Biol Anim. 2023 Sep;59(8):624-635. doi: 10.1007/s11626-023-00808-9. Epub 2023 Sep 20. In Vitro Cell Dev Biol Anim. 2023. PMID: 37728854

7

New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry.

Shi D, Zhao H, Bu C, Fraser K, Wang H, Dordick JS, Linhardt RJ, Zhang F, Shi F, Chi L. Shi D, et al. J Thromb Haemost. 2023 Dec;21(12):3608-3618. doi: 10.1016/j.jtha.2023.08.020. Epub 2023 Aug 28. J Thromb Haemost. 2023. PMID: 37648114

8

Platelet factor 4 induces bone loss by inhibiting the integrin α5-FAK-ERK pathway.

Li W, Zhang Q, Gu R, Zeng L, Liu H. Li W, et al. Animal Model Exp Med. 2023 Dec;6(6):573-584. doi: 10.1002/ame2.12342. Epub 2023 Aug 11. Animal Model Exp Med. 2023. PMID: 37565509 Free PMC article.

9

Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity.

Greinacher A, Warkentin TE. Greinacher A, et al. Int J Lab Hematol. 2023 Jun;45 Suppl 2:11-22. doi: 10.1111/ijlh.14075. Epub 2023 May 7. Int J Lab Hematol. 2023. PMID: 37150909 Review.

10

An Evaluation of Platelet Factor 4, Beta-Thromboglobulin and Mean Platelet Volume in the Assessment of Thrombotic Risks in Subjects with Diabetes Mellitus at Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.

Dada AO, Dada OA, Akinbami AA, Bamiro AR, Uche IE, Adeyemi OI, Kareem OA, Okunowo OB, Dosu MR. Dada AO, et al. West Afr J Med. 2023 Apr 28;40(4):357-361. West Afr J Med. 2023. PMID: 37115730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

237 results

Results by year